Sanofi's quadrivalent flu shot safe in kids; No increased risk to babies for H1N1 vax in pregnancy;

> Sanofi Pasteur's quadrivalent version of its Fluzone flu vaccine was safe and effective in a Phase III trial in children aged 6 months to 8 years. Press release

> There is no evidence of increases in fetal death in pregnant women receiving a pandemic A/H1N1 influenza vaccine during pregnancy. Abstract

> Inovio's SynCon vaccine for cervical dysplasias and cancers has been granted a U.S. patent. Article

> Profectus has received an NIAID grant to develop a vaccine against Ebola and Marburg viruses. Press release

> Galena Biopharma ($GALE) has received a notice of allowance for a U.S. patent for folate binding protein vaccines. Press release

And Finally… Allergy Therapeutics, which specializes in allergy vaccines, has appointed Dr. Thomas Lander as a non-executive director. Press release

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.